drugset / Trial / NCT00325000

Interpersonal Psychotherapy for Severely Depressed Inpatients

NCT00325000

RandomizedParallel-groupOpen-labelTreatment

Summary

We examined the hypotheses that severely depressed inpatients treated for 5 weeks with IPT-S plus pharmacotherapy have 1) a higher reduction in depressive symptoms and 2) higher response- and remission rates compared to pharmacotherapy plus CM. For the follow-up period (12 months) we hypothesized a better symptomatic and psychosocial longterm outcome and lower rates of relapse for patients initially treated with combination therapy.

Timeline

Start
2000-11
Primary completion
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Background Amitriptyline Small molecule
Background Sertraline Small molecule